[1] FDA - Lexiva Prescribing Information, 03/05/08, p. 18. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [2] FDA - Drugs Used in the Treatment of HIV Infection. Available at: http://www.fda.gov/oashi/aids/virals.html. Accessed 05/27/08. [3] AHFS Drug Information - 2008; p. 648 [4] AHFS Drug Information - 2008; p. 648 [5] FDA - Lexiva Prescribing Information, 03/05/08, p. 38. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [6] FDA - Lexiva Prescribing Information, 03/05/08, p. 2. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [7] FDA - Lexiva Prescribing Information, 03/05/08, p. 2. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [8] FDA - Lexiva Prescribing Information, 03/05/08, p. 2. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [9] FDA - Lexiva Prescribing Information, 03/05/08, p. 3. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [10] FDA - Lexiva Prescribing Information, 03/05/08, p. 2. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [11] FDA - Lexiva Prescribing Information, 03/05/08, p. 3. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [12] FDA - Lexiva Prescribing Information, 03/05/08, p. 43. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [13] FDA - Lexiva Prescribing Information, 03/05/08, p. 3. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [14] FDA - Lexiva Prescribing Information, 03/05/08, p. 3. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [15] FDA - Lexiva Prescribing Information, 03/05/08, p. 3. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [16] FDA - Lexiva Prescribing Information, 03/05/08, p. 38. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [17] FDA - Lexiva Prescribing Information, 03/05/08, p. 38. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [18] FDA - Lexiva Prescribing Information, 03/05/08, p. 32. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [19] FDA - Lexiva Prescribing Information, 03/05/08, pp. 19, 21. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [20] FDA - Lexiva Prescribing Information, 03/05/08, p. 21. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [21] FDA - Lexiva Prescribing Information, 03/05/08, p. 20. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [22] FDA - Lexiva Prescribing Information, 03/05/08, p. 21. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [23] FDA - Lexiva Prescribing Information, 03/05/08, p. 21. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [24] FDA - Lexiva Prescribing Information, 03/05/08, p. 37. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [25] FDA - Lexiva Prescribing Information, 03/05/08, p. 38. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [26] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 05/27/08. [27] FDA - Lexiva Prescribing Information, 03/05/08, p. 17. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [28] FDA - Lexiva Prescribing Information, 03/05/08, pp. 32-3. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [29] Pharm GKB - Fosamprenavir Prescribing Information. Available at: http://www.pharmgkb.org. Accessed 05/27/08. [30] FDA - Lexiva Prescribing Information, 03/05/08, p. 10. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [31] FDA - Lexiva Prescribing Information, 03/05/08, pp. 5, 8. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [32] FDA - Lexiva Prescribing Information, 03/05/08, p. 6. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [33] FDA - Lexiva Prescribing Information, 03/05/08, pp. 5-6. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [34] FDA - Lexiva Prescribing Information, 03/05/08, p. 6. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [35] FDA - Lexiva Prescribing Information, 03/05/08, p. 6. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [36] FDA - Lexiva Prescribing Information, 03/05/08, p. 2. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [37] FDA - Lexiva Prescribing Information, 03/05/08, p. 21. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [38] FDA - Lexiva Prescribing Information, 03/05/08, p. 2. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [39] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 05/27/08. [40] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 05/27/08. [41] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 05/27/08. [42] FDA - Lexiva Prescribing Information, 03/05/08, p. 13. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [43] FDA - Lexiva Prescribing Information, 03/05/08, p. 13. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [44] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 05/27/08. [45] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 05/27/08. [46] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 05/27/08. [47] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 05/27/08. [48] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 05/27/08. [49] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 05/27/08. [50] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 05/27/08. [51] FDA - Lexiva Prescribing Information, 03/05/08, p. 3. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [52] FDA - Lexiva Prescribing Information, 03/05/08, p. 5. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [53] ChemIDplus - Available at: http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp. Accessed 05/27/08. [54] ChemIDplus - Available at: http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp. Accessed 05/27/08. [55] ChemIDplus - Available at: http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp. Accessed 05/27/08. [56] Calculation. - [57] Merck Index - 2006; p. 729 [58] Merck Index - 2006; p. 729 [59] FDA - Lexiva Prescribing Information, 03/05/08, p. 3. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [60] FDA - Lexiva Prescribing Information, 03/05/08, p. 3. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 05/27/08. [61] Merck Index - 2006; p. 729 [62] ChemIDplus - Available at: http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp. Accessed 05/27/08. [63] Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection - MMWR 2002;51 (No.RR-7) Updated as a Living Document on February 28, 2008. Available at: http://aidsinfo.nih.gov/contentfiles/PediatricGuidelines.pdf. Accessed 05/27/08.
|